15 results
10-Q
2024 Q1
IMCR
Immunocore Holdings plc
8 May 24
Quarterly report
7:00am
approvals, manufacture drug product and drug supply, maintain and expand our intellectual property portfolio, as well as hire additional personnel, pay
10-K
2023 FY
IMCR
Immunocore Holdings plc
28 Feb 24
Annual report
7:33am
intellectual property portfolio;
acquire or in-license other product candidates, intellectual property and technologies;
hire additional clinical … or will hire, requiring us to train new sales representatives. If we are unable to effectively train our sales force and equip them with effective
10-K
2023 FY
EX-10.12
IMCR
Immunocore Holdings plc
28 Feb 24
Annual report
7:33am
are due pursuant to this Section for any tax year, Company shall, at its expense, hire a “Big 4” accounting firm to prepare Executive’s Home
10-K
2023 FY
EX-10.13
IMCR
Immunocore Holdings plc
28 Feb 24
Annual report
7:33am
, Company shall, at its expense, hire a “Big 4” accounting firm to prepare Executive’s Home-Jurisdictions tax returns, prepare all other applicable
20-F
i8fjdg af5iy2s
25 Mar 21
Annual report (foreign)
7:01am
424B4
syy8 209w08
8 Feb 21
Prospectus supplement with pricing info
8:36am
F-1/A
ce1m 6lz57g9h5t
3 Feb 21
Registration statement (foreign) (amended)
5:22pm
F-1/A
EX-10.18
hpo kas50r
1 Feb 21
Registration statement (foreign) (amended)
6:21am
F-1/A
fy8jx8 31wzxr
1 Feb 21
Registration statement (foreign) (amended)
6:21am
F-1
0s86h n0kv
15 Jan 21
Registration statement (foreign)
4:57pm
F-1
EX-10.10
8qgl51rg4l5y
15 Jan 21
Registration statement (foreign)
4:57pm
DRS/A
EX-10.9
3sihww py
22 Dec 20
Draft registration statement (amended)
12:00am
DRS/A
deg onydr6
19 Nov 20
Draft registration statement (amended)
12:00am
DRS
52tc8ri2krlm95jhmswc
17 Nov 20
Draft registration statement
12:00am
- Prev
- 1
- Next